Advanced search
Publication Cover
Gynecological Endocrinology Volume 38, 2022 - Issue 10
Submit an article Journal homepage
1,573
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Hormone therapy in endometrial cancer survivors: time for a change

Angelo Cagnaccia Academic Unit of Obstetrics and Gynecology, IRCCS- San Martino Hospital of Genova, Genova, Italy; ;b Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Infant Health (DiNOGMI), University of Genova, Genova, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2714-623XView further author information
ORCID Icon &
Ambrogio P. Londerob Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Infant Health (DiNOGMI), University of Genova, Genova, ItalyView further author information
Pages 795-796 | Received 31 May 2022, Accepted 19 Sep 2022, Published online: 28 Sep 2022

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249.
  • Crosbie EJ, Kitson SJ, McAlpine JN, et al. Endometrial cancer. Lancet. 2022;399(10333):1412–1428.
  • Matsuo K, Mandelbaum RS, Matsuzaki S, et al. Ovarian conservation for young women with Early-Stage, Low-Grade endometrial cancer: a 2-Step schema. Am J Obstet Gynecol. 2021;224(6):574–584.
  • Matsuo K, Cripe JC, Kurnit KC, et al. Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer. Gynecol Oncol. 2019;155(1):39–50.
  • Jia P, Zhang Y. Ovarian preservation improves overall survival in young patients with early-stage endometrial cancer. Oncotarget. 2017;8(35):59940–59949.
  • Baber RJ, Panay N, Fenton A, IMS Writing Group. 2016 IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150.
  • Cagnacci A, Gambacciani M, Gallo M, Executive Committee of the Italian Society of Menopause (SIM) and of the Italian Society of Gynecology of the Third Age (SIGiTE), et al. Recommendations on menopausal hormone replacement therapy. Minerva Ginecol. 2019;71(6):395–403.
  • Woopen H, Sehouli J, Davis A, et al. GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: a position paper from the gynecologic cancer intergroup (GCIG) symptom benefit committee. Cancer Treatment Rev. 2022;107:102396.
  • Soisson S, Ganz PA, Gaffney D, et al. Long-term cardiovascular outcomes among endometrial cancer survivors in a large, population-based cohort study. J Natl Cancer Inst. 2018;110(12):1342–1351.
  • Westin SN, Sun CC, Tung CS, et al. Survivors of gynecologic malignancies: impact of treatment on health and well-being. J Cancer Surviv. 2016;10(2):261–270.
  • Felix AS, Bower JK, Pfeiffer RM, et al. High cardiovascular disease mortality after endometrial cancer diagnosis: results from the surveillance, epidemiology, and end results (SEER) database. Int J Cancer. 2017;140(3):555–564.
  • Londero AP, Parisi N, Tassi A, et al. Hormone replacement therapy in endometrial cancer survivors: a meta-analysis. JCM. 2021;10(14):3165.
  • Shim SH, Lee SJ, Kim SN. Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis. Eur J Cancer. 2014;50(9):1628–1637.
  • Gien L, Kwon J, Oliver TK, the Members of the Gynecology Cancer Disease Site Group, et al. Adjuvant hormonal therapy for stage I endometrial cancer. Curr Oncol. 2008;15(3):126–135.
  • Bartosch C, Monteiro-Reis S, Vieira R, et al. Endometrial endometrioid carcinoma metastases show decreased ER-Alpha and PR-a expression compared to matched primary tumors. PLoS One. 2015;10(8):e0134969.
  • Suriano KA, McHale M, McLaren CE, et al. Estrogen replacement therapy in endometrial cancer patients: a matched control study. Obstet Gynecol. 2001;97(4):555–560.
  • Catherino WH, Eltoukhi HM, Al-Hendy A. Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma. Semin Reprod Med. 2013;31(5):370–379. [InsertedFromOnline

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.